- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04973397
Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study (VALIANCE)
March 17, 2026 updated by: Centre hospitalier de l'Université de Montréal (CHUM)
Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study - A Prospective Observational Cohort Study Evaluating Major Cardiovascular and Adverse Events in Patients Undergoing Elective Same-day Noncardiac Surgery
The proportion of noncardiac surgeries performed as same-day surgery is increasing worldwide, with more complex surgeries being performed on higher risk patients in the outpatient setting.
Little is known on the risk factors, incidence and prognosis of patients undergoing same-day noncardiac surgery.
The main objective of this study is to inform on the incidence and risk factors of cardiovascular and other adverse events after same-day surgery and to develop risk prediction tools to better inform on the risk and selection of patients undergoing same-day surgery.
Study Overview
Status
Recruiting
Detailed Description
The VALIANCE Study is a 15,000 patient, multicentre, prospective observational cohort of adults undergoing elective same-day noncardiac surgery and who will be followed for 90 days after surgery.
The primary objective of the study is to determine the incidence of major cardiovascular complications after same-day surgery.
Patients will also be followed for the occurence of other adverse postoperative complications and determine their change in quality of life at 90 days after surgery.
VALIANCE will inform on the risk factors for postoperative complications and allow to develop risk prediction tools to guide patient selection and risk stratification of patients undergoing same-day surgery.
The study will also look at validating the use of the Duke Activity Status Index questionnaire, Clinical Frailty Scale, and the Revised Cardiac Risk Index.
Postoperative pain will be evaluated using the Brief pain inventory score and quality of life using the EQ-5D-5L questionnaire.
Study Type
Observational
Enrollment (Estimated)
15000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Melodie Fanay Boko, MSc
- Phone Number: 31541 514-890-8000
- Email: melodie.fanay.boko.chum@ssss.gouv.qc.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada
- Recruiting
- Hamilton General Hospital
-
Contact:
- John Harlock, MD, MSc
-
Hamilton, Ontario, Canada
- Recruiting
- Juravinski Hospital and Cancer Centre
-
Contact:
- Ameen Patel, MD
-
Hamilton, Ontario, Canada
- Recruiting
- McMaster University Medical Centre
-
Contact:
- Jessica Spence, MD, PhD
-
Hamilton, Ontario, Canada, L8N 4A6
- Active, not recruiting
- St-Joseph's Healthcare Hamilton
-
Toronto, Ontario, Canada, M5G 1X5
- Recruiting
- Mount Sinai Hospital
-
Contact:
- James Khan, MD
-
Toronto, Ontario, Canada, M5T 2S8
- Recruiting
- Toronto Western Hospital
-
Contact:
- Mandeep Singh, MBBS, MD, MSc, FRCPC
-
Toronto, Ontario, Canada
- Recruiting
- St-Micheal's Hospital
-
Contact:
- Duminda M Wijeysundera, MD, PhD
-
-
Quebec
-
Montreal, Quebec, Canada, H2X0C1
- Recruiting
- Centre Hospitalier de l'Universite de Montreal (CHUM)
-
Contact:
- Melodie Fanay Boko, BSc
- Phone Number: 31541 514-890-8000
- Email: melodie.fanay.boko.chum@ssss.gouv.qc.ca
-
Principal Investigator:
- Emmanuelle Duceppe, MD, PhD
-
Sherbrooke, Quebec, Canada
- Active, not recruiting
- Centre Hospitalier Universitaire de Sherbrooke
-
-
-
-
-
Rotterdam, Netherlands
- Recruiting
- Maasstad Ziekenhuis Rotterdam
-
Contact:
- Joseph Koopman, MD, PhD
-
-
-
-
-
Barcelona, Spain
- Recruiting
- Hospital Clinic Barcelona
-
Contact:
- Eva Rivas, MD, PhD
-
-
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Recruiting
- Wake Forest Baptist Medical Centre
-
Contact:
- Ashish K Khanna, MD, MSc
-
-
Ohio
-
Cleveland, Ohio, United States, 44111
- Recruiting
- Cleveland Clinic Foundation Fairview Campus
-
Contact:
- Sabry Ayad, MD, MBA
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic Foundation Main Campus
-
Contact:
- Daniel Sessler, MD
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- MD Anderson Cancer Center
-
Contact:
- Juan P Cata, MD
-
Houston, Texas, United States, 77030
- Recruiting
- Memorial Hermann Texas Medical Center UT Health
-
Contact:
- Mehmet Alparslan Turan, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All eligible adults undergoing elective same-day noncardiac surgery
Description
Inclusion Criteria:
- 45-64 years of age with at least one risk factor, or ≥65 years of age;
- undergoing elective noncardiac same-day surgery;
- planned duration in the operating room 60 minutes or more;
- provided written consent.
Exclusion Criteria:
- intervention does not require the presence of an anesthesiologist;
- procedure is performed by a nonsurgical specialty (e.g., gastroenterology, pneumology, radio-oncology or radiology);
- intervention is an ophthalmologic procedure;
- previously enrolled in the VALIANCE study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unplanned healthcare utilization
Time Frame: 90 days
|
the number of patients who have at least one of the following: unplanned admission after surgery, unplanned outpatient visit, emergency room visit and rehospitalization after same-day surgery
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
unplanned admission
Time Frame: 90 days
|
the number of patients who have to be admitted to the hospital after undergoing a surgery planned as same-day
|
90 days
|
|
unplanned outpatient visit
Time Frame: 90 days
|
the number of patient who had a medical visit in an outpatient setting after undergoing same-day surgery
|
90 days
|
|
emergency room visit
Time Frame: 90 days
|
the number of patients who visited the emergency room without subsequent hospitalization after undergoing same-day surgery
|
90 days
|
|
re-hospitalization
Time Frame: 90 days
|
the number of patients who have to be readmitted to the hospital after being discharged home following their same-day surgery
|
90 days
|
|
major cardiovascular complications
Time Frame: 90 days
|
the number of patients who have at least one of the following: myocardial injury or infarction, non-fatal cardiac arrest, coronary revascularization, stroke, transient ischemic attack, new clinically significant arrythmia, congestive heart failure, unplanned postoperative admission for vascular reasons, emergency room visit for vascular reasons, rehospitalization for vascular reasons, and all-cause mortality
|
90 days
|
|
myocardial injury after noncardiac surgery (MINS)
Time Frame: 90 days
|
the number of patients who experience a MINS
|
90 days
|
|
myocardial infarction
Time Frame: 90 days
|
the number of patients who experience a myocardial infarction
|
90 days
|
|
non-fatal cardiac arrest
Time Frame: 90 days
|
the number of patients who experience a non-fatal cardiac arrest
|
90 days
|
|
coronary revascularization
Time Frame: 90 days
|
the number of patients who undergo coronary revascularization
|
90 days
|
|
stroke
Time Frame: 90 days
|
the number of patients who experience a stroke
|
90 days
|
|
transient ischemic attack
Time Frame: 90 days
|
the number of patients who experience a transient ischemic attack
|
90 days
|
|
new clinically important arrythmia
Time Frame: 90 days
|
the number of patients who experience a new clinically important arrythmia
|
90 days
|
|
acute congestive heart failure
Time Frame: 90 days
|
the number of patients who experience an acute congestive heart failure episode
|
90 days
|
|
deep vein thrombosis
Time Frame: 90 days
|
the number of patients who experience a deep vein thrombosis
|
90 days
|
|
pulmonary embolism
Time Frame: 90 days
|
the number of patients who experience a pulmonary embolism
|
90 days
|
|
major postoperative and life-threatening bleeding
Time Frame: 90 days
|
the number of patients who experience a major postoperative and/or life-threatening bleeding
|
90 days
|
|
postoperative infection
Time Frame: 90 days
|
the number of patients who experience a postoperative infection
|
90 days
|
|
acute kidney injury
Time Frame: 90 days
|
the number of patients who experience a acute kidney injury
|
90 days
|
|
quality of life score on the 5-level EQ-5D version (EQ-5D-5L) questionnaire
Time Frame: 90 days
|
score on the EQ-5D-5L questionnaire on 4 health profiles (level 1 to 5), overall self-rated health status (0-100 visual analogue scale), and EQ-5D-5L index value (0.01-0.99)
|
90 days
|
|
functional capacity score on the Duke Activity Status Index (DASI)
Time Frame: 90 days
|
change in the score on the Duke Activity Status Index (DASI) questionnaire (0 to 58.2 points)
|
90 days
|
|
frailty
Time Frame: 90 days
|
change in the level on the Clinical Frailty Scale (level 1 to 9)
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Emmanuelle Duceppe, MD, PhD, Centre Hospitalier de l'Universite de Montreal (CHUM)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 17, 2021
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
July 13, 2021
First Submitted That Met QC Criteria
July 13, 2021
First Posted (Actual)
July 22, 2021
Study Record Updates
Last Update Posted (Actual)
March 19, 2026
Last Update Submitted That Met QC Criteria
March 17, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MP-02-2022-9889
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
Beijing Northland Biotech. Co., Ltd.Not yet recruitingAcute Myocardial Infarction (AMI) | Acute Myocardial Infarction of Anterior Wall | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction With ST Segment Elevation | Acute Myocardial Infarction of Left VentricleChina
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SAWithdrawn
-
Samsung Medical CenterThe Korean Society of CardiologyNot yet recruiting
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationCompletedST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionUnited States, Spain, Netherlands, Canada, Australia, Serbia, Egypt, Switzerland, Hungary, United Kingdom, France, Czechia, Nepal, North Macedonia
-
Harbin Medical UniversityNot yet recruitingNon-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)Acute Myocardial Infarction (AMI) | ST-Segment Elevation Myocardial Infarction(STEMI) | Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)China
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom